Chargement en cours...
The Biguanides Metformin and Buformin in Combination with 2-Deoxy-glucose or WZB-117 Inhibit the Viability of Highly Resistant Human Lung Cancer Cells
The biguanides metformin (MET) and to a lesser extent buformin (BUF) have recently been shown to exert anticancer effects. In particular, MET targets cancer stem cells (CSCs) in a variety of cancer types but these compounds have not been extensively tested for combination therapy. In this study, we...
Enregistré dans:
| Publié dans: | Stem Cells Int |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6409035/ https://ncbi.nlm.nih.gov/pubmed/30918522 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/6254269 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|